Your browser is out-of-date!

Update your browser to view this website correctly.

To continue, please select your country of domicile and investor type. Depending on your domicile and the investor type that you select, you will have full or restricted access to the information due to legal reasons.

Retail clients: according to Art. 4 Abs. 2 FinSA

Professional/Institutional investors: according to Art. 4 paragraph 3-5 and Art. 5 paragraph 1 and 3-4 FinSA and Art. 10 paragraph 3 and 3ter CISA in conjunction with Art. 6a CISO

Important Principles

By using the website, you confirm that you have read, understood and accepted the general information provided by the Bellevue Group AG as well as these legal provisions. These may be subject to change and the use of the site may be restricted or terminated at any time without prior notice.

The information, products, data, services, tools and documents contained or described on this site ("website content") are for information purposes only and constitute neither an advertisement or recommendation nor an offer or solicitation (to buy) or redemption (sell) investment instruments, to effect any transaction or to enter into any legal relations.

The financial products mentioned on this site are not suitable for all investors. The information contained on this site does not constitute a financial, legal, fiscal or any other recommendation. Investment or other decisions should not be made solely on the basis of this document. In particular, you should not enter into any investment before you have read the corresponding fund agreement or legal prospectus, the annual and semi-annual reports, the articles of association (as far as they are applicable), as well as all other documents, as required in accordance with local legislation or the regulations applied in the legal jurisdictions or countries in which the corresponding investment fund has been licensed or approved for public offer or sale to the public.

In order to determine whether the investment in shares of a certain investment fund meets your specific requirements and matches your envisaged risks, we recommend that you contact an independent financial adviser. Furthermore, we recommend that you consult an independent tax adviser in order to obtain information on the tax regulations relating to a specific investment in your legal jurisdiction and with regard to your personal circumstances. In particular tax treatment depends on individual circumstances and may be subject to change.


Past performance is not an indication or guarantee of the future performance of the investment. The value of investments may be subject to fluctuations and, under certain circumstances, investors may not get back the full amount invested. Changes in foreign-exchange rates may also cause the value of investments to go up or down.

For a full explanation of risks and the overall risk profile of financial products mentioned on this site, please refer to the relevant Key Investor Information Documents (KIDs) and Prospectuses.

Data protection

By accessing this website you state that you agree with the data protection statement. If you do not agree with this statement you should refrain from accessing any further pages of this website. This statement may be updated at any time. We therefore recommend that you check this statement regularly.


By clicking on "Accept", you confirm that you agree to the legal provisions. Alternatively, you can select "I don't accept" if you wish to leave the website.

Excellence in Healthcare Investments

Bellevue – one of the largest healthcare investors
Bellevue Asset Management (UK) Ltd. is part of the Bellevue Group, a Swiss investment manager listed on the Swiss stock exchange (SWX: BBN), and authorised and regulated by the Financial Conduct Authority. Founded in 1993, Bellevue is one of the largest and most experienced healthcare investors in Europe.
Across our platforms, the commonality is rigorous bottom up analysis and stock selection within a top-down macro overlay, be it sectoral or geographical specialisation or an over-arching theme. It is widely appreciated that the demographic drivers of healthcare consumption are inexorable; it is the secular growth story of our age.

Our offering

Differentiated approaches for the rapidly evolving healthcare paradigm

  • Global healthcare

    Global healthcare

    Bellevue Healthcare strategies seek to exploit a long-term secular growth theme in healthcare. We invest in a concentrated portfolio of listed or quoted global companies providing new approaches to transform what we view as fundamentally broken healthcare systems around the world.

  • biotechnology


    Since its foundation in 1993, BB Biotech has offered investors direct access to a select portfolio of promising, fast growing and profitable biotech companies  listed on stock markets around the world. Thanks to its strong track record over the years and its systematic strategy and clear focus, it has become one of the world’s largest biotech investors.

A strong commitment to excellent Healthcare investment performance sustained by quality, specialization and innovation is key to our success since 1993.